FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022189687> ?p ?o ?g. }

• W2022189687 endingPage "255" @default.
• W2022189687 startingPage "250" @default.
• W2022189687 abstract "The aim of the study was to investigate the ocular hypotensive activity of a nitric oxide (NO)-donating latanoprost, BOL-303259-X, following topical administration. The effect of BOL-303259-X (also known as NCX 116 and PF-3187207) on intraocular pressure (IOP) was investigated in monkeys with laser-induced ocular hypertension, dogs with naturally-occurring glaucoma and rabbits with saline-induced ocular hypertension. Latanoprost was used as reference drug. NO, downstream effector cGMP, and latanoprost acid were determined in ocular tissues following BOL-303259-X administration as an index of prostaglandin and NO-mediated activities. In primates, a maximum decrease in IOP of 31% and 35% relative to baseline was achieved with BOL-303259-X at doses of 0.036% (9 μg) and 0.12% (36 μg), respectively. In comparison, latanoprost elicited a greater response than vehicle only at 0.1% (30 μg) with a peak effect of 26%. In glaucomatous dogs, IOP decreased from baseline by 44% and 10% following BOL-303259-X (0.036%) and vehicle, respectively. Latanoprost (0.030%) lowered IOP by 27% and vehicle by 9%. Intravitreal injection of hypertonic saline in rabbits increased IOP transiently. Latanoprost did not modulate this response, whereas BOL-303259-X (0.036%) significantly blunted the hypertensive phase. Following BOL-303259-X treatment, latanoprost acid was significantly elevated in rabbit and primate cornea, iris/ciliary body and aqueous humor as was cGMP in aqueous humor. BOL-303259-X lowered IOP more effectively than latanoprost presumably as a consequence of a contribution by NO in addition to its prostaglandin activity. The compound is now in clinical development for the treatment of glaucoma and ocular hypertension." @default.
• W2022189687 created "2016-06-24" @default.
• W2022189687 creator A5006197686 @default.
• W2022189687 creator A5007995825 @default.
• W2022189687 creator A5040207336 @default.
• W2022189687 creator A5054982559 @default.
• W2022189687 creator A5061951892 @default.
• W2022189687 creator A5077892371 @default.
• W2022189687 creator A5080776915 @default.
• W2022189687 creator A5090452749 @default.
• W2022189687 creator A5091104086 @default.
• W2022189687 creator A5091860060 @default.
• W2022189687 date "2011-09-01" @default.
• W2022189687 modified "2023-10-02" @default.
• W2022189687 title "Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating Prostaglandin F2α agonist, in preclinical models" @default.
• W2022189687 cites W1972351498 @default.
• W2022189687 cites W1973757121 @default.
• W2022189687 cites W1983742520 @default.
• W2022189687 cites W1985689227 @default.
• W2022189687 cites W1995888380 @default.
• W2022189687 cites W2010755453 @default.
• W2022189687 cites W2012889162 @default.
• W2022189687 cites W2050860348 @default.
• W2022189687 cites W2051653587 @default.
• W2022189687 cites W2052894008 @default.
• W2022189687 cites W2059589670 @default.
• W2022189687 cites W2066098313 @default.
• W2022189687 cites W2069881405 @default.
• W2022189687 cites W2076260416 @default.
• W2022189687 cites W2077590596 @default.
• W2022189687 cites W2080504583 @default.
• W2022189687 cites W2092033036 @default.
• W2022189687 cites W2168238963 @default.
• W2022189687 cites W4255191103 @default.
• W2022189687 doi "https://doi.org/10.1016/j.exer.2011.03.001" @default.
• W2022189687 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21396362" @default.
• W2022189687 hasPublicationYear "2011" @default.
• W2022189687 type Work @default.
• W2022189687 sameAs 2022189687 @default.
• W2022189687 citedByCount "96" @default.
• W2022189687 countsByYear W20221896872012 @default.
• W2022189687 countsByYear W20221896872013 @default.
• W2022189687 countsByYear W20221896872014 @default.
• W2022189687 countsByYear W20221896872015 @default.
• W2022189687 countsByYear W20221896872016 @default.
• W2022189687 countsByYear W20221896872017 @default.
• W2022189687 countsByYear W20221896872018 @default.
• W2022189687 countsByYear W20221896872019 @default.
• W2022189687 countsByYear W20221896872020 @default.
• W2022189687 countsByYear W20221896872021 @default.
• W2022189687 countsByYear W20221896872022 @default.
• W2022189687 countsByYear W20221896872023 @default.
• W2022189687 crossrefType "journal-article" @default.
• W2022189687 hasAuthorship W2022189687A5006197686 @default.
• W2022189687 hasAuthorship W2022189687A5007995825 @default.
• W2022189687 hasAuthorship W2022189687A5040207336 @default.
• W2022189687 hasAuthorship W2022189687A5054982559 @default.
• W2022189687 hasAuthorship W2022189687A5061951892 @default.
• W2022189687 hasAuthorship W2022189687A5077892371 @default.
• W2022189687 hasAuthorship W2022189687A5080776915 @default.
• W2022189687 hasAuthorship W2022189687A5090452749 @default.
• W2022189687 hasAuthorship W2022189687A5091104086 @default.
• W2022189687 hasAuthorship W2022189687A5091860060 @default.
• W2022189687 hasConcept C118487528 @default.
• W2022189687 hasConcept C134018914 @default.
• W2022189687 hasConcept C2776521421 @default.
• W2022189687 hasConcept C2776740260 @default.
• W2022189687 hasConcept C2776882836 @default.
• W2022189687 hasConcept C2777397205 @default.
• W2022189687 hasConcept C2778527774 @default.
• W2022189687 hasConcept C2779526769 @default.
• W2022189687 hasConcept C2780664492 @default.
• W2022189687 hasConcept C2781092963 @default.
• W2022189687 hasConcept C519581460 @default.
• W2022189687 hasConcept C71924100 @default.
• W2022189687 hasConcept C98274493 @default.
• W2022189687 hasConceptScore W2022189687C118487528 @default.
• W2022189687 hasConceptScore W2022189687C134018914 @default.
• W2022189687 hasConceptScore W2022189687C2776521421 @default.
• W2022189687 hasConceptScore W2022189687C2776740260 @default.
• W2022189687 hasConceptScore W2022189687C2776882836 @default.
• W2022189687 hasConceptScore W2022189687C2777397205 @default.
• W2022189687 hasConceptScore W2022189687C2778527774 @default.
• W2022189687 hasConceptScore W2022189687C2779526769 @default.
• W2022189687 hasConceptScore W2022189687C2780664492 @default.
• W2022189687 hasConceptScore W2022189687C2781092963 @default.
• W2022189687 hasConceptScore W2022189687C519581460 @default.
• W2022189687 hasConceptScore W2022189687C71924100 @default.
• W2022189687 hasConceptScore W2022189687C98274493 @default.
• W2022189687 hasIssue "3" @default.
• W2022189687 hasLocation W20221896871 @default.
• W2022189687 hasLocation W20221896872 @default.
• W2022189687 hasOpenAccess W2022189687 @default.
• W2022189687 hasPrimaryLocation W20221896871 @default.
• W2022189687 hasRelatedWork W1965052468 @default.
• W2022189687 hasRelatedWork W1988894620 @default.
• W2022189687 hasRelatedWork W2044315218 @default.
• W2022189687 hasRelatedWork W2054254645 @default.

• next